Switch Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States11-50 Employees

Switch Therapeutics is a preclinical biotechnology company based in San Francisco, California, focused on developing medicines that target disease processes in the central nervous system and systemic indications with unmet medical needs. The company advances a novel RNA-based approach to gene knockdown, integrating nucleic acid nanotechnology with RNA interference to create conditionally activated RNAi activity that aims to achieve cell-selective effects. Its proprietary platform, CASi, combines properties of different RNA forms within a single molecule to enable targeted gene silencing, positioning Switch within the broader field of RNA therapeutics. The team operates in an emerging area of biotechnology research, pursuing preclinical development and the progression of its CASi platform to build a pipeline of potential treatments. Recent organizational updates include leadership appointments and board additions to support its scientific and operational growth in South San Francisco as research progresses.

Sign up for free to view info

Company overview Email format